Episode Details

Back to Episodes
E24: NMDA Receptor Antagonists: Ketamine, Esketamine, and Dextromethorphan+Bupropion

E24: NMDA Receptor Antagonists: Ketamine, Esketamine, and Dextromethorphan+Bupropion

Season 1 Episode 24 Published 1 year, 3 months ago
Description
Today we have an interesting episode. We are covering the first of a very new class of antidepressants, the NMDA receptor antagonists. These are the first antidepressants approved for use for depression which do not interact with the monoamine system, and many more may be coming out in the future. We will talk about ketamine, its sister, esketamine, and the only oral form, a combination of the cough suppressant dextromethorphan and bupropion. Find out how this new class of antidepressant works for depression and what my opinion is of these new medications!
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us